Clinical Trial Update: Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of adding aliskiren to standardized losartan and optimized antihypertensive therapy in patients with hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Aliskiren (Aliskiren)
• Losartan (losartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED